Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 18, Issue 20, Pages 5672-5675Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.08.072
Keywords
protein kinase CK1 delta; kinase inhibitors; structure-based virtual screening; molecular docking
Categories
Funding
- Italian Ministry for University and Research (MIUR), Rome, Italy
- University of Padova, Padova, Italy
- AIRC (Italian Association for Cancer Research)
- European Commission [LSHBCT2004-503467]
Ask authors/readers for more resources
In eukaryotes, protein phosphorylation of serine, threonine or tyrosine residues by protein kinases plays an important role in many cellular processes. Members of the protein kinase CK1 family usually phosphorylate residues of serine that are close to other phosphoserine in a consensus motif of pS-X-X-S, and they are implicated in the regulation of a variety of physiological processes as well as in pathologies like cancer and Alzheimer's disease. Using a structure-based virtual screening (SBVS) approach we have identified two anthraquinones as novel CK1 delta inhibitors. These amino-anthraquinone analogs (derivatives 1 and 2) are among the most potent and selective CK1 delta inhibitors known today (IC50 = 0.3 and 0.6 mu M, respectively). (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available